HIGHLIGHTS
- who: Olivier Demaria from the CNRS Hôpital de la Timone, Immunology, Marseille Immunopole, Marseille, France have published the research work: Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19, in the Journal: (JOURNAL) of 15/06/2020
SUMMARY
Received Published Cellular and amp; Molecular Immunology 17:995 - 997 incubation with monalizumab an anti-NKG2A mAb blocking the inhibitory interaction with HLA-E, was able to unleash their killing ability (Fig 1g). These data suggest that therapeutic interventions may improve NK cell functions, facilitating virus elimination, and support the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.